Scott Koenig
President and CEO at MacroGenics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Crescent Biopharma Inc., 3 years.
Crescent Biopharma Inc.
Director
MacroGenics Inc.
Director · President and CEO
Chief executive roles
MacroGenics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2024 | MacroGenics Inc. | Gift | −374,215 | — | — |
| Sep 23, 2024 | MacroGenics Inc. | Gift | +374,215 | — | — |
| Feb 15, 2024 | MacroGenics Inc. | Option exercise | +42,341 | — | — |
| Feb 15, 2024 | MacroGenics Inc. | Shares withheld for tax | −14,349 | $17.40 | $249,673 |
| Jun 1, 2023 | Crescent Biopharma Inc. | Option exercise | +21,000 | $0.60 | $12,600 |
| Jan 27, 2023 | Crescent Biopharma Inc. | Option exercise | +10,500 | $2.55 | $26,775 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.